Cargando…
Anakinra or high-dose corticosteroids in COVID-19 pneumonia patients who deteriorate on low-dose dexamethasone: an observational study of comparative effectiveness
OBJECTIVES: To assess whether escalating to high-dose corticosteroids or anakinra compared with continuing low-dose corticosteroids reduced mortality in patients with severe COVID-19 whose respiratory function deteriorated while receiving dexamethasone 6 mg daily. METHODS: We conducted a retrospecti...
Autores principales: | Langer-Gould, Annette, Xu, Stanley, Myers, Laura C., Chen, Aiyu, Greene, John D., Creekmur, Beth, Bruxvoort, Katia, Adams, John L., Liu, Vincent, Gould, Michael K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673073/ https://www.ncbi.nlm.nih.gov/pubmed/36403818 http://dx.doi.org/10.1016/j.ijid.2022.11.017 |
Ejemplares similares
-
High-dose corticosteroids in patients hospitalized for COVID-19 pneumonia: an observational study of comparative effectiveness
por: Langer-Gould, Annette, et al.
Publicado: (2022) -
The impact of timing of initiating invasive mechanical ventilation in COVID-19-related respiratory failure
por: Myers, Laura C., et al.
Publicado: (2023) -
Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab
por: Langer-Gould, Annette, et al.
Publicado: (2020) -
Low-dose corticosteroid combined with immunoglobulin reverses deterioration in severe cases with COVID-19
por: Zhou, Zhi-Guo, et al.
Publicado: (2020) -
Could anakinra outmatch dexamethasone/tocilizumab in COVID-19?
por: Gupta, Rahul
Publicado: (2022)